Ajanta Pharma Ltd

ACROSS is the first truly global, agile CRO alliance. Offering cost effective, cutting edge innovative solutions for small/medium pharmaceutical and biotech companies as well as public health institutes and non-governmental organizations, ACROSS is the latest player on the global field of clinical trials.

ACROSS Global is an entirely new business model, providing enhanced and innovative global solutions through highly qualified, globally experienced, knowledgeable local experts. ACROSS Global identifies, analyses and mitigates risks across the entire clinical research spectrum, with an agility and focus to the envy of competitors. We provide value added solutions individually tailored for small and mid-size companies.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. It has been growing at about 25.5% CAGR over the last 5 years and crossed the $1.9 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 69% of its revenue coming from global business.

Currently ranked 9th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology and Oncology in India. It is also known for its range of products in other hospital-based therapeutic segments in the EU and US.

Intas operates 15 formulation, R&D and distribution facilities, of which 10 are in India, and the rest in the UK and Mexico. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars and NDDS products.

Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “biosimilars for billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.

The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP certified manufacturing facility complemented with a GLP compliant QC lab.

Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces of our excellence.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated."

Founded in 1984 with headquarters in Hyderabad, India, VIMTA LABS LTD., is a leading contract research and testing organization, providing bio/pharmaceutical companies an integrated scientific, technical and regulatory expertise to support all stages of drug development and manufacturing process. Our service portfolio includes preclinical and clinical research; and cGMP laboratory services viz., method development, microbiology, stability testing, extractables & leachables, process validation, quality control, physical characterization etc.

In our 34 years of journey, we have gained in-depth scientific and technical expertise through working with a variety of molecules and formulations in different therapeutic areas. We support the needs of more than 300 bio/pharmaceutical companies across the globe, from virtual to large pharma and biopharma through a wide range of expertise. Our team of 1000+ professionals constantly endeavor to provide timely scientific solutions and services to help customers manage their drug development and manufacturing processes more efficiently, without compromising on quality.

We have a track record of strict compliance to regulatory requirements (cGMP, GLP, GCP) and Standards (ISO 17025, ISO 15189, ISO 9001), and have undergone over 40 regulatory audits successfully from regulatory agencies across the globe including DCGI, NGCMA, USFDA, WHO, MHRA, ANSM, ANVISA, BfArM and DRAs of Denmark, Sweden, Portugal and Ukraine.

DeNova Sciences Pte. Limited is a Contract Research Organisation that specialises in Dermatology Solutions. Our one-stop platform offers customisable testing solutions that utilises in-vitro 3D skin and fresh ASIAN human skin explants to match the industry's research and commercialisation needs.

These platforms help to address the increasing demand from personal care and nutrition industry on product efficacy and claim. Our services are not limited to only product testing but also in personalised outsourced R&D, product commercialisation and regulation consultancy for personal care products.

With years of experience, DeNova has collaborated with many industry leaders and renowned research institutes to improve our technologies and innovative capabilities to ensure premium service for all our clients.